# CVR Partners, LP: financial statements, quarterly

UAN · NYSE · CIK 1425292 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uan.md) · [Financials](/companies/uan/financials.md) · [Filings](/companies/uan/filings.md) · [Insiders](/companies/uan/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uan/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [131](/filings/0001425292-24-000021.md) | [142 d](/filings/0001425292-26-000011.md) | [128](/filings/0001425292-25-000015.md) | [133](/filings/0001425292-25-000022.md) | [125](/filings/0001425292-25-000030.md) | [140 d](/filings/0001425292-26-000011.md) | [143](/filings/0001425292-26-000022.md) | [169](/filings/0001425292-26-000031.md) | [164](/filings/0001425292-25-000030.md) | [131 d](/filings/0001425292-26-000011.md) | [180](/filings/0001425292-26-000022.md) | [202](/filings/0001425292-26-000031.md) |
| Cost of revenue | $m | [114](/filings/0001425292-24-000021.md) | [117 d](/filings/0001425292-26-000011.md) | [100](/filings/0001425292-25-000015.md) | [93.0](/filings/0001425292-25-000022.md) | [107](/filings/0001425292-25-000030.md) | [106 d](/filings/0001425292-26-000011.md) | [100](/filings/0001425292-26-000022.md) | [114](/filings/0001425292-26-000031.md) | [103](/filings/0001425292-25-000030.md) | [125 d](/filings/0001425292-26-000011.md) | [113](/filings/0001425292-26-000022.md) | [109](/filings/0001425292-26-000031.md) |
| Selling, general and administrative | $m | [7.8](/filings/0001425292-24-000021.md) | [7.0 d](/filings/0001425292-26-000011.md) | [7.3](/filings/0001425292-25-000015.md) | [6.3](/filings/0001425292-25-000022.md) | [7.4](/filings/0001425292-25-000030.md) | [7.3 d](/filings/0001425292-26-000011.md) | [7.9](/filings/0001425292-26-000022.md) | [8.0](/filings/0001425292-26-000031.md) | [9.2](/filings/0001425292-25-000030.md) | [8.5 d](/filings/0001425292-26-000011.md) | [9.0](/filings/0001425292-26-000022.md) | [7.5](/filings/0001425292-26-000031.md) |
| Operating income | $m | [8.1](/filings/0001425292-24-000021.md) | [17.2 d](/filings/0001425292-26-000011.md) | [20.1](/filings/0001425292-25-000015.md) | [33.6](/filings/0001425292-25-000022.md) | [11.0](/filings/0001425292-25-000030.md) | [25.7 d](/filings/0001425292-26-000011.md) | [34.6](/filings/0001425292-26-000022.md) | [46.3](/filings/0001425292-26-000031.md) | [50.6](/filings/0001425292-25-000030.md) | [(2.9) d](/filings/0001425292-26-000011.md) | [57.6](/filings/0001425292-26-000022.md) | [84.8](/filings/0001425292-26-000031.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001425292-24-000021.md) | [0.2 d](/filings/0001425292-26-000011.md) | [(0.0)](/filings/0001425292-25-000015.md) | [0.0](/filings/0001425292-25-000022.md) | [0.0](/filings/0001425292-25-000030.md) | [0.1 d](/filings/0001425292-26-000011.md) | [0.0](/filings/0001425292-26-000022.md) | [0.0](/filings/0001425292-26-000031.md) | [0.0](/filings/0001425292-25-000030.md) | [(0.0) d](/filings/0001425292-26-000011.md) | [0.0](/filings/0001425292-26-000022.md) | [0.0](/filings/0001425292-26-000031.md) |
| Net income | $m | [0.7](/filings/0001425292-24-000021.md) | [10.0 d](/filings/0001425292-26-000011.md) | [12.6](/filings/0001425292-25-000030.md) | [26.2](/filings/0001425292-25-000030.md) | [3.8](/filings/0001425292-25-000030.md) | [18.3 d](/filings/0001425292-26-000011.md) | [27.1](/filings/0001425292-26-000031.md) | [38.8](/filings/0001425292-26-000031.md) | [43.1](/filings/0001425292-25-000030.md) | [(10.3) d](/filings/0001425292-26-000011.md) | [49.9](/filings/0001425292-26-000031.md) | [77.5](/filings/0001425292-26-000031.md) |
| Diluted EPS | $ per share | [0.07](/filings/0001425292-24-000021.md) | not reported | [1.19](/filings/0001425292-25-000015.md) | [2.48](/filings/0001425292-25-000022.md) | [0.36](/filings/0001425292-25-000030.md) | not reported | [2.56](/filings/0001425292-26-000022.md) | [3.67](/filings/0001425292-26-000031.md) | [4.08](/filings/0001425292-25-000030.md) | not reported | [4.72](/filings/0001425292-26-000022.md) | [7.33](/filings/0001425292-26-000031.md) |
| Basic EPS | $ per share | [0.07](/filings/0001425292-24-000021.md) | not reported | [1.19](/filings/0001425292-25-000015.md) | [2.48](/filings/0001425292-25-000022.md) | [0.36](/filings/0001425292-25-000030.md) | not reported | [2.56](/filings/0001425292-26-000022.md) | [3.67](/filings/0001425292-26-000031.md) | [4.08](/filings/0001425292-25-000030.md) | not reported | [4.72](/filings/0001425292-26-000022.md) | [7.33](/filings/0001425292-26-000031.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [89.2](/filings/0001425292-23-000029.md) | [45.3](/filings/0001425292-25-000004.md) | [64.6](/filings/0001425292-24-000008.md) | [47.5](/filings/0001425292-24-000012.md) | [111](/filings/0001425292-24-000021.md) | [90.9](/filings/0001425292-26-000011.md) | [122](/filings/0001425292-25-000015.md) | [114](/filings/0001425292-25-000022.md) | [156](/filings/0001425292-25-000030.md) | [69.2](/filings/0001425292-26-000031.md) | [128](/filings/0001425292-26-000022.md) | [137](/filings/0001425292-26-000031.md) |
| Current assets | $m | [203](/filings/0001425292-23-000029.md) | [166](/filings/0001425292-25-000004.md) | [182](/filings/0001425292-24-000008.md) | [184](/filings/0001425292-24-000012.md) | [227](/filings/0001425292-24-000021.md) | [234](/filings/0001425292-26-000011.md) | [247](/filings/0001425292-25-000015.md) | [242](/filings/0001425292-25-000022.md) | [289](/filings/0001425292-25-000030.md) | [214](/filings/0001425292-26-000031.md) | [271](/filings/0001425292-26-000022.md) | [315](/filings/0001425292-26-000031.md) |
| Total assets | $m | [1,019](/filings/0001425292-23-000029.md) | [975](/filings/0001425292-25-000004.md) | [972](/filings/0001425292-24-000008.md) | [959](/filings/0001425292-24-000012.md) | [987](/filings/0001425292-24-000021.md) | [1,019](/filings/0001425292-26-000011.md) | [1,014](/filings/0001425292-25-000015.md) | [998](/filings/0001425292-25-000022.md) | [1,037](/filings/0001425292-25-000030.md) | [969](/filings/0001425292-26-000031.md) | [1,018](/filings/0001425292-26-000022.md) | [1,057](/filings/0001425292-26-000031.md) |
| Current liabilities | $m | [113](/filings/0001425292-23-000029.md) | [75.5](/filings/0001425292-25-000004.md) | [79.5](/filings/0001425292-24-000008.md) | [59.5](/filings/0001425292-24-000012.md) | [105](/filings/0001425292-24-000021.md) | [111](/filings/0001425292-26-000011.md) | [98.9](/filings/0001425292-25-000015.md) | [70.3](/filings/0001425292-25-000022.md) | [108](/filings/0001425292-25-000030.md) | [96.8](/filings/0001425292-26-000031.md) | [98.6](/filings/0001425292-26-000022.md) | [105](/filings/0001425292-26-000031.md) |
| Long-term debt | $m | [547](/filings/0001425292-23-000029.md) | [547](/filings/0001425292-24-000021.md) | [547](/filings/0001425292-24-000008.md) | [548](/filings/0001425292-24-000012.md) | [548](/filings/0001425292-24-000021.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [70.1 d](/filings/0001425292-24-000021.md) | [(17.9) d](/filings/0001425292-26-000011.md) | [42.4](/filings/0001425292-25-000015.md) | [8.6 d](/filings/0001425292-25-000022.md) | [86.7 d](/filings/0001425292-25-000030.md) | [12.8 d](/filings/0001425292-26-000011.md) | [55.4](/filings/0001425292-26-000022.md) | [24.1 d](/filings/0001425292-26-000031.md) | [91.7 d](/filings/0001425292-25-000030.md) | [(21.6) d](/filings/0001425292-26-000011.md) | [75.8](/filings/0001425292-26-000022.md) | [65.9 d](/filings/0001425292-26-000031.md) |
| Capital expenditure | $m | [6.2 d](/filings/0001425292-24-000021.md) | [10.5 d](/filings/0001425292-26-000011.md) | [8.1](/filings/0001425292-25-000015.md) | [6.2 d](/filings/0001425292-25-000022.md) | [4.5 d](/filings/0001425292-25-000030.md) | [18.3 d](/filings/0001425292-26-000011.md) | [9.9](/filings/0001425292-26-000022.md) | [5.7 d](/filings/0001425292-26-000031.md) | [11.6 d](/filings/0001425292-25-000030.md) | [23.6 d](/filings/0001425292-26-000011.md) | [17.0](/filings/0001425292-26-000022.md) | [15.0 d](/filings/0001425292-26-000031.md) |
| Share repurchases | $m | [0.0 d](/filings/0001425292-23-000029.md) | [0.0 d](/filings/0001425292-25-000004.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.6](/filings/0001425292-23-000029.md) | [10.6](/filings/0001425292-24-000008.md) | [10.6](/filings/0001425292-24-000012.md) | [10.6](/filings/0001425292-24-000021.md) | [10.6](/filings/0001425292-25-000015.md) | [10.6](/filings/0001425292-25-000022.md) | [10.6](/filings/0001425292-25-000030.md) | [10.6](/filings/0001425292-26-000022.md) | [10.6](/filings/0001425292-26-000031.md) | [10.6](/filings/0001425292-25-000030.md) | [10.6](/filings/0001425292-26-000022.md) | [10.6](/filings/0001425292-26-000031.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,569,637 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0001425292-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.